ID: ALA4644914

Max Phase: Preclinical

Molecular Formula: C51H49F3N12O7

Molecular Weight: 999.02

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(C(=O)Nc2ccc(CN3CCN(C(=O)CCCc4cn(CCOCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)nn4)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12

Standard InChI:  InChI=1S/C51H49F3N12O7/c1-32-10-11-34(27-33(32)13-15-38-29-56-43-8-4-18-57-66(38)43)47(69)58-36-14-12-35(40(28-36)51(52,53)54)30-62-20-22-63(23-21-62)45(68)9-2-5-37-31-64(61-60-37)24-26-73-25-19-55-41-7-3-6-39-46(41)50(72)65(49(39)71)42-16-17-44(67)59-48(42)70/h3-4,6-8,10-12,14,18,27-29,31,42,55H,2,5,9,16-17,19-26,30H2,1H3,(H,58,69)(H,59,67,70)

Standard InChI Key:  VCIZNIVXZWDIOC-UHFFFAOYSA-N

Associated Targets(Human)

Cereblon/BCR/ABL 220 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 999.02Molecular Weight (Monoisotopic): 998.3799AlogP: 4.50#Rotatable Bonds: 16
Polar Surface Area: 218.36Molecular Species: NEUTRALHBA: 15HBD: 3
#RO5 Violations: 2HBA (Lipinski): 19HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.59CX Basic pKa: 5.77CX LogP: 4.76CX LogD: 4.75
Aromatic Rings: 6Heavy Atoms: 73QED Weighted: 0.07Np Likeness Score: -1.56

References

1. Yang Y, Gao H, Sun X, Sun Y, Qiu Y, Weng Q, Rao Y..  (2020)  Global PROTAC Toolbox for Degrading BCR-ABL Overcomes Drug-Resistant Mutants and Adverse Effects.,  63  (15): [PMID:32657579] [10.1021/acs.jmedchem.0c00967]

Source